MolNFT v1 · #8021 · protein
Monitoring the structural consequences of PHE12-->D-PHE12 and LEU15-->AIB15 substitution in H/R corticotropin releasing hormone: implications for design of crh antagonists.
1GOE: “Monitoring the structural consequences of PHE12-->D-PHE12 and LEU15-->AIB15 substitution in H/R corticotropin…”. Solution nmr. MolNFT v1 #8021 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 1GOE
- Type
- protein
- Length
- 41 residues
- Chains
- 1
- Method
- solution nmr
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P06850
Structure
solution nmr · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 41 | — | P06850 |
Compared structures
- 1GOE · Monitoring the structural Consequences of Phe12-->D-Phe12 and Leu15-->Aib15 substitution… · the same entry in another collection · chain A against A, TM-score 1.00
- P06850 · AlphaFold monomer V2.0 prediction for corticoliberin (P06850) · a predicted model of the same protein · chain A against A, TM-score 0.57
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P06850
- Elsewhere: RCSB PDB 1GOE · PDBe 1GOE · UniProt P06850
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.